(Q38046574)

27 August 2017

title

Understanding the biology of triple-negative breast cancer (English)

1 reference

27 August 2017

1 reference

C Criscitiello

1

1 reference

27 August 2017

H A Azim

2

1 reference

27 August 2017

P C Schouten

3

1 reference

27 August 2017

S C Linn

4

1 reference

27 August 2017

C Sotiriou

5

1 reference

27 August 2017

publication date

1 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

23 Suppl 6

1 reference

27 August 2017

page(s)

vi13-8

1 reference

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Management of triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Clinical relevance of TNM staging system according to breast cancer subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Triple negative tumours: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Metaplastic breast carcinomas are basal-like tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Beyond triple-negative breast cancer: the need to define new subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

How basal are triple-negative breast cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Genetic alterations and oncogenic pathways associated with breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

DNA copy number alterations and expression of relevant genes in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

A gene expression signature identifies two prognostic subgroups of basal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Multifactorial approach to predicting resistance to anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Targeting epidermal growth factor receptor--are we missing the mark?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS188

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS188

1 reference

27 August 2017

1 reference